Scleromyxedema with subcutaneous nodules: Successful treatment with thalidomide and intravenous immunoglobulin

18Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, intravenous immunoglobulin (IVIg) appears to be the therapy of choice for scleromyxedema. Treatment experiences in atypical manifestations with mucinous nodules are limited to sporadic reports. We report the case of male patient with atypical scleromyxedema without underlying paraproteinemia, presenting with generalized papular and sclerodermoid skin eruption and multiple nodular mucinous lesions on the fingers and face as well as on the eyelids, and associated systemic symptoms. Complete regression of all cutaneous lesions and extracutaneous symptoms with sustained remission was achieved by combined treatment with thalidomide and IVIg. © 2013 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Dolenc-Voljč, M., Jurčić, V., Hočevar, A., & Tomšič, M. (2013). Scleromyxedema with subcutaneous nodules: Successful treatment with thalidomide and intravenous immunoglobulin. Case Reports in Dermatology, 5(3), 309–315. https://doi.org/10.1159/000356469

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free